PharmaNutra SpAMIL:PHN +0.34%86 Buyback Yield % is 0.13 as of Jul. 06, 2026, which is at its 10-year median of 0.13. GuruFocus rates MIL:PHN with a GF Score™ of 86/100 and a GF Value™ of €71.68 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 291 Drug Manufacturers companies, PharmaNutra SpA ranks better than 72.85% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for PharmaNutra SpA's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:PHN vs ZTS, UTHR, VTRS: Buyback Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PharmaNutra SpA's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PharmaNutra SpA Buyback Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PharmaNutra SpA's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where PharmaNutra SpA's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PharmaNutra SpA (MIL:PHN) has a Buyback Yield % of 0.13 as of Jul. 06, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on PharmaNutra SpA and its competitors. This is near median its historical median of 0.13. According to the industry distribution chart, PharmaNutra SpA ranks #79 out of 291 companies in the Drug Manufacturers industry, placing it in the top 27.1%.
Is PharmaNutra SpA's Buyback Yield % too high?
PharmaNutra SpA's current Buyback Yield % of 0.13 is near median its 10-year median of 0.13. Based on the distribution chart, PharmaNutra SpA ranks #79 out of 291 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, PharmaNutra SpA has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PharmaNutra SpA's Buyback Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PharmaNutra SpA ranks #79 out of 291 companies for Buyback Yield %. This puts PharmaNutra SpA in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on PharmaNutra SpA and its competitors. PharmaNutra SpA's current Buyback Yield % is 0.13, which is near median its own 10-year median of 0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaNutra SpA stock overvalued right now?
Based on GuruFocus' analysis, PharmaNutra SpA (MIL:PHN) is currently considered Modestly Overvalued. The stock's GF Value™ is €71.68, compared to a current price of €89.50 — trading 24.9% above its estimated fair value. The current Buyback Yield % is 0.13, which is near median its 10-year median of 0.13. PharmaNutra SpA's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For PharmaNutra SpA (MIL:PHN), the current Buyback Yield % is 0.13 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PharmaNutra SpA (MIL:PHN) Overvalued in 2026?
Based on GuruFocus' analysis, PharmaNutra SpA stock appears to be overvalued.
The current stock price of €89.50 is trading 24.9% above its estimated GF Value™ of €71.68.
GuruFocus considers PharmaNutra SpA to be Modestly Overvalued.
Key valuation signals for MIL:PHN:
Buyback Yield %: 0.13 (near median its 10-year median of 0.13)
GF Value™: €71.68 vs. price of €89.50 (24.9% above fair value)
No single metric tells the full story. See the MIL:PHN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PharmaNutra SpA is a pharmaceutical company. The company is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. The products of the company include SiderAL Folic, UltraMag, Cetilar, and others. The company operates in Europe, the Middle East, South America, the Far East, and other regions.
86GF Score
Get the complete analysis for MIL:PHN
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:PHN has been successfully added to your 
